-
Hot News: Celsion Corp. (NASDAQ:CLSN), Transition Therapeutics Inc. (NASDAQ:TTHI), NMI Holdings (NASDAQ:NMIH), Summer Infant (NASDAQ:SUMR), Cempra (NASDAQ:CEMP)
On Monday shares of Celsion Corp. (NASDAQ:CLSN) closed at $2.65. Celsion Corporation (NASDAQ:CLSN) reported the publication of an abstract in the prestigious Journal of Controlled Release summarizing findings from a preclinical study confirming effective delivery of RNA to lung cells. Transition Therapeutics Inc. (NASDAQ:TTHI) in last trading activity increased 3.62% to close at $6.93. Company…
-
Hot Stock List: Celsion Corp. (NASDAQ:CLSN), Tribune Publishing Company (NYSE:TPUB), Microsoft Corporation (NASDAQ:MSFT), General Electric Company (NYSE:GE), Royal Caribbean Cruises (NYSE:RCL)
On Friday shares of Celsion Corp. (NASDAQ:CLSN) closed at $2.47. Celsion Corporation (NASDAQ:CLSN) announced on 30 April, an update on its clinical development plans for GEN-1, the Company’s DNA-based immunotherapy for the localized treatment of cancer, in ovarian cancer. GEN-1 has demonstrated promising clinical activity and tolerability in platinum-resistant and recurrent ovarian cancer patients, as…
-
Active Stocks to Watch: Cytori Therapeutics (NASDAQ:CYTX), Celsion Corp. (NASDAQ:CLSN), Magellan Petroleum Corporation (NASDAQ:MPET), Layne Christensen Company (NASDAQ:LAYN), Sony Corp (NYSE:SNE)
On Wednesday shares of Cytori Therapeutics, Inc. (NASDAQ:CYTX) closed at $1.15. On 9 April, Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products, has designated Cytori’s ECCS-50 cellular therapeutic as an orphan medicinal product for the treatment of scleroderma. This…
-
Stock in News: Celsion Corp. (NASDAQ:CLSN), Cyberark Software Ltd (NASDAQ:CYBR), The Dow Chemical (NYSE:DOW), Brixmor Property (NYSE:BRX), New Media Investment (NYSE:NEWM)
Celsion Corp. (NASDAQ:CLSN) today presented clinical and preclinical data demonstrating the safety, biological activity and clinical benefits of GEN-1, its DNA-based immunotherapy, as a single agent in advanced platinum-resistant and recurrent ovarian cancer patients, at the Molecular Medicine TRI-Conference in San Francisco. On Friday shares of Celsion Corp. (NASDAQ:CLSN) closed at $3.15. Company’s sales growth…
-
Why These Are Hot: Celsion Corp. (NASDAQ:CLSN), Radio One Inc. (NASDAQ:ROIAK), Incyte Corporation (NASDAQ:INCY), Corning Inc. (NYSE:GLW), MAXIMUS (NYSE:MMS)
On 20 February, Celsion Corp. (NASDAQ:CLSN) presented clinical and preclinical data demonstrating the safety, biological activity and clinical benefits of GEN-1, its DNA-based immunotherapy, as a single agent in advanced platinum-resistant and recurrent ovarian cancer patients, at the Molecular Medicine TRI-Conference in San Francisco. On Friday shares of Celsion Corp. (NASDAQ:CLSN) closed at $3.15. Company’s…
-
5 Stocks: Celsion Corp. (NASDAQ:CLSN), Chesapeake Granite Wash Trust (NYSE:CHKR), Mountain Province Diamonds Inc. (NASDAQ:MDM), Enzymotec (NASDAQ:ENZY), Zillow (NASDAQ:Z)
On February 20, it was reported that, Celsion Corporation (NASDAQ:CLSN) presented clinical and preclinical data demonstrating the safety, biological activity and clinical benefits of GEN-1, its DNA-based immunotherapy, as a single agent in advanced platinum-resistant and recurrent ovarian cancer patients, at the Molecular Medicine TRI-Conference in San Francisco. These data provide support for advancing GEN-1…
-
Notable Moves: AT&T (NYSE:T), Glu Mobile (NASDAQ:GLUU), Ford Motor Co. (NYSE:F), Celsion Corp. (NASDAQ:CLSN), The Dow Chemical Company (NYSE:DOW)
AT&T, Inc. (NYSE:T) expands its smart grid leadership by making it easier for utilities and solution providers to develop cellular solutions with the development of a Cellular Communications Module (CCM) Reference Design with an integrated Prepay Energy management application. The CCM Reference Design addresses the demand for accelerated cellular adoption of Internet of Things (IoT)…
-
5 Stocks: Gilead Sciences Inc. (NASDAQ:GILD), Taylor Morrison Home Corporation (NYSE:TMHC), Under Armour (NYSE:UA), General Motors Company (NYSE:GM), Celsion Corp. (NASDAQ:CLSN)
Gilead Sciences Inc (NASDAQ: GILD) won another exclusive deal for its Hepatitis C drug, when it signed with the Catamaran Corp. On Wednesday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $98.43. Company’s sales growth for last 5 years was 16.00% and EPS growth for next 5 years is recorded as 33.42%. Taylor Morrison Home…
-
Biotech Stocks New Lows: Histogenics Corporation (NASDAQ:HSGX), Cleveland BioLabs (NASDAQ:CBLI), Theravance Inc. (NASDAQ:THRX), Celsion Corp. (NASDAQ:CLSN), VIVUS Inc. (NASDAQ:VVUS)
BTIG Research initiated coverage on shares of Histogenics Corp (NASDAQ:HSGX) in a research report released on Friday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $13.00 price objective on the stock. On Wednesday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $7.11. Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced that at a special meeting…
-
Traders Are Gambling on: Phillips 66 (NYSE:PSX), Regions Financial Corporation (NYSE:RF), Celsion Corp. (NASDAQ:CLSN), Demandware (NYSE:DWRE), Brookfield Residential Properties Inc. (NYSE:BRP)
Phillips 66 (NYSE:PSX) was downgraded by TheStreet from a “buy” rating to a “hold” rating in a research note issued on Wednesday. On Tuesday shares of Phillips 66 (NYSE:PSX) closed at $63.62. Company’s EPS growth for next 5 years is recorded as 14.05%. Regions Financial Corp. (NYSE:RF) reported that its total 2014 net income was…